From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...
Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...
Hosted on MSN14h
Gilead reports positive HIV PrEP data for lenacapavirGilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...
Opinion
16hon MSNOpinion
To end the Latino HIV crisis, health programs must be developed, tailored and evolve to meet the health needs and preferences of our diverse Latino communities.
Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...
People on MSN9d
Man Born with HIV Shares How He and His Wife Are Expecting an HIV-Negative Baby: 'I Was Able to Break a Cycle' (Exclusive)Joseph Kibler and his wife, Carey Cox, shared that they're expecting a baby who will be HIV-negative, despite Kibler's ...
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...
HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or ...
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
The free contraceptives will be accompanied by 45,500 educational pamphlets on HIV/AIDS, 3,000 pre- and post-exposure ...
(HealthDay News) — The supply of health care professionals available to provide HIV care is expected to continue to decline over the next 5 years, according to research published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback